-
- Galderma Reports Strong Start to the Year, Delivering First Quarter 2026 Net Sales of 1.473 Billion USD, Growing 25.5% at Constant Currency
- Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026. · Strong start to the year delivering net sales of 1,473 million ...
- 16:33
-
- Galderma Shareholders Approve All Annual General Meeting Proposals
- Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, announced that shareholders approved all proposals put forward by the Board of Directors at its Annual General Meeting (AGM), held ear...
- 15:51
-
- 크라운 바이오사이언스-터빈, AI 기반 예측과 오가노이드 검증을 연결하는 중개 종양학 파트너십 체결
- 글로벌 위탁연구기관(CRO)이자 JSR 라이프 사이언스(JSR Life Sciences) 계열사인 크라운 바이오사이언스(Crown Bioscience)는 선도적 가상 생물학 기업 터빈(Turbine)과 전략적 파트너십을 체결해, 터빈의 인실리코(in sil...
- 15:00
더보기
